When Anxiety and Depression Overlap, Medication Often Falls Short
You may be experiencing:
- →Racing thoughts that won’t slow down even when you’re exhausted
- →Constant low-level worry that feels impossible to switch off
- →Physical tension — tight chest, shallow breathing, restlessness
- →Avoiding situations that used to feel normal
- →Anxiety that gets worse when depression is present
- →Medication that dulls the anxiety but takes too much else with it
Anxiety and depression co-occur in a significant number of patients — and when they do, each condition tends to amplify the other. Treating one without addressing both rarely produces lasting results.
Patients across Fort Lauderdale and Delray Beach often describe anxiety as the symptom that controls their daily decisions — what they avoid, what they can’t commit to, what keeps them up at night. TMS has shown meaningful results for this combined presentation.
When anxiety and depression overlap, the brain needs more than chemical regulation. It needs direct retraining.
When Anxiety and Depression Overlap, Medication Often Falls Short
Many antidepressants prescribed for anxiety-depression combinations carry their own side effect burden — sedation, emotional blunting, weight changes. Benzodiazepines offer short-term relief but carry dependency risks that most patients and providers want to avoid.
TMS does not sedate, does not create dependency, and does not require ongoing medication management. It works by directly stimulating the neural circuits involved in mood and emotional regulation — circuits that are often disrupted in both anxiety and depression.
Calming the Brain — Not Just Masking the Symptoms
Targets mood and emotional regulation directly
NeuroStar stimulates the prefrontal cortex — the region responsible for regulating emotional responses, worry, and the anxiety-depression cycle.
No sedation — no dependency risk
TMS does not sedate or create the dependency concerns associated with anti-anxiety medications. You stay alert, functional, and in control throughout treatment.
Calming effect builds over time
Unlike medication that requires constant dosing, TMS retrains neural activity. Many patients describe a gradual quieting of the anxiety response as treatment progresses.
Fits your schedule completely
20-minute sessions, five days a week. West Palm Beach and Boca Raton patients integrate treatment without any disruption to work or daily life.
Step by Step — From Evaluation to Relief
Free Consultation & Insurance Check
We review your treatment history, confirm your diagnosis, and verify insurance before anything else happens.
Personalized Brain Mapping
Your first session calibrates the device to your anatomy — identifying the exact location and magnetic intensity for your treatment.
36 Sessions Over 7–9 Weeks
Five sessions per week, approximately 20 minutes each. Drive yourself — no downtime, no disruption to your day.
Progress Monitoring Throughout
We track your symptom changes with validated tools and adjust the protocol if your response calls for it.
Sustained Relief
Many patients maintain meaningful improvement for one year or more following treatment completion.
A Life With Less Anxiety — Specific and Real
These are the changes patients describe — not generic wellness language, but specific shifts in daily experience.
Breathing room in your own thoughts
The mental noise that anxiety creates — constant background worry — begins to quiet. Thoughts feel less urgent, less consuming.
Making commitments again
Avoiding plans, conversations, or responsibilities out of anxiety. Patients describe gradually being able to show up for things they had been pulling back from.
Sleeping without the mind racing
Anxiety-driven insomnia — the kind where you’re exhausted but your brain won’t stop — often improves significantly during TMS treatment.
Feeling present with people
Not managing how you appear or rehearsing conversations. Actually being in the moment with the people around you.
The Research Behind the Results
of patients in NeuroStar clinical trials responded with meaningful reduction in depression symptoms.
achieved full remission — no longer meeting the clinical threshold for major depressive disorder.
average duration of sustained symptom relief reported in long-term follow-up studies.
Results based on NeuroStar TMS clinical study data. Individual results may vary.
Heard From South Florida Patients
I had anxiety and depression at the same time and nothing fully addressed both. TMS was the first treatment where I felt the anxiety actually lift — not get pushed down, but genuinely reduce. Three months later it’s still holding.
I was afraid medication would be the only option forever. TMS changed that. The worry that used to run everything started to quiet around week four. I hadn’t felt that calm in years.
My anxiety made it hard to leave the house some days. TMS helped me get back to a life I recognized. No sedation, no side effects. Just gradual improvement, session by session.
What Patients Ask Before Starting
Other Conditions We Help With
Emotional Numbness
Anxiety and emotional numbness often coexist — feeling wound up and disconnected at the same time.
Learn more →
Treatment-Resistant Depression
When anxiety accompanies depression that hasn’t responded to medication, TMS addresses both together.
Learn more →
Mental Exhaustion
Chronic anxiety is exhausting. Learn how TMS helps restore mental energy alongside emotional stability.
Learn more →
Ready to Find Out if TMS Can Help Your Anxiety?
A free 30-minute consultation is the first step. We verify insurance before you commit and answer every question before you decide.
Important Safety Information
NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. NeuroStar TMS Therapy is only available by prescription. The most common side effect is pain or discomfort at or near the treatment site. This is usually mild to moderate in severity and typically resolves within the first week of treatment. Rare risk of seizure (<0.1% per patient). For full safety information, visit neurostar.com.